CPHI: China Pharma Holdings, Inc. Company Value to Net Income

Symbol and logo of brand China Pharma Holdings, Inc. (CPHI)

The China Pharma Holdings (CPHI) price chart demonstrates the -4.40 metric, while the business implements robotic lines for tablet packaging and pressing to reduce manual labor. Local Chinese supply chains and a distributor network guarantee stable deliveries to pharmacies. China Pharma Holdings (CPHI) also produces affordable vitamins and generics, whose profitability relies on government procurement and the sales volumes of low-cost medications.

CPHI (China Pharma Holdings, Inc.) Price to Earnings Ratio history from 07/04/2022 to 11/18/2026

Comprehensive metric breakdowns and analytics for chinapharmaholdings.com (CPHI)

- market capitalization information:
Summary company analysis:China Pharma Holdings Inc. - CPHI
Original product of China Pharma Holdings

China Pharma Holdings (CPHI) ensures stable demand for basic generics, demonstrating high resilience to macroeconomic shocks. Current capitalization correlates with net profit, forming the basis for calculating fundamental value. This ratio measures the investment payback period through the relationship between market price and earnings. For a non-cyclical pharmaceutical business, this is a key indicator of undervaluation. By analyzing the P/E valuation multiple, an investor can identify temporary gaps between price and real assets.